Search research articles
Contact Us
Filters
Showing results (121-130 of 126) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 126 results.
Addiction (Abingdon, England)
|
June 17, 2022
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial
M Eugenia Socias, Evan Wood, Bernard Le Foll, et al.
The International Journal on Drug Policy
|
April 29, 2017
Canadian harm reduction policies: A comparative content analysis of provincial and territorial documents, 2000-2015
T Cameron Wild, Bernie Pauly, Lynne Belle-Isle, et al.
Plos One
|
May 19, 2021
Public support for harm reduction: A population survey of Canadian adults
T Cameron Wild, Jakob Koziel, Jalene Anderson-Baron, et al.
Health Promotion and Chronic Disease Prevention in Canada : Research, Policy and Practice
|
September 17, 2025
The relationship between COVID-19 and opioid-related emergency department visits in Alberta, Canada: an interrupted time series analysis
Kelsey A Speed, Hauwa Bwala, Nicole D Gehring, et al.
The American Journal of Psychiatry
|
June 15, 2022
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial
Didier Jutras-Aswad, Bernard Le Foll, Keith Ahamad, et al.
Neuroimage
|
July 12, 2012
Effects of emotional context on impulse control
Matthew R G Brown, R Marc Lebel, Florin Dolcos, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 126) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 126 results.
Addiction (Abingdon, England)
|
June 17, 2022
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial
M Eugenia Socias, Evan Wood, Bernard Le Foll, et al.
The International Journal on Drug Policy
|
April 29, 2017
Canadian harm reduction policies: A comparative content analysis of provincial and territorial documents, 2000-2015
T Cameron Wild, Bernie Pauly, Lynne Belle-Isle, et al.
Plos One
|
May 19, 2021
Public support for harm reduction: A population survey of Canadian adults
T Cameron Wild, Jakob Koziel, Jalene Anderson-Baron, et al.
Health Promotion and Chronic Disease Prevention in Canada : Research, Policy and Practice
|
September 17, 2025
The relationship between COVID-19 and opioid-related emergency department visits in Alberta, Canada: an interrupted time series analysis
Kelsey A Speed, Hauwa Bwala, Nicole D Gehring, et al.
The American Journal of Psychiatry
|
June 15, 2022
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial
Didier Jutras-Aswad, Bernard Le Foll, Keith Ahamad, et al.
Neuroimage
|
July 12, 2012
Effects of emotional context on impulse control
Matthew R G Brown, R Marc Lebel, Florin Dolcos, et al.
Page
of 13